New medicines in primary care: a review of influences on general practitioner prescribing

Journal of Clinical Pharmacy and Therapeutics
A Mason

Abstract

The uptake of new medicines is slower in the UK than in many other countries. Previous research found that cost and price have little influence on general practitioner (GP) behaviour, but recent UK government policy may have heightened cost-consciousness. Focussing on new medicines, this review aimed to explore the determinants of uptake, the causes of geographical variations, and the influence of price, cost and financial incentives on prescribing behaviour. Two separate searches were conducted on nine electronic databases. Strategy 1, an update of a previous review, used key terms for primary care physicians, uptake, medicines and 'new'. Strategy 2 focussed on terms relating to incentives and prescribing. Records were screened for eligibility and data from relevant papers were extracted using Bonair and Persson's typology for determinants of the diffusion of innovation, which classified influences into three groups: actors, structural/environmental characteristics and product characteristics. The searches identified 550 records and 28 studies were included in the updated review. Prescribing of new medicines needs to be understood in the context of individual patient-centred care, which is characterized by stability and contin...Continue Reading

References

Nov 5, 1988·BMJ : British Medical Journal·A Williams
Mar 7, 2002·Health Policy·Jörg RuofJ-Matthias Graf von der Schulenburg
Jan 22, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jennifer D GuoAlex Z Fu
Jan 25, 2003·BMJ : British Medical Journal·Ahmet FuatJeremy James Murphy
Mar 29, 2003·BMJ : British Medical Journal·Stephen ChapmanRichard Neary
Jul 19, 2003·Journal of Health Services Research & Policy·Stephen HarrisonIan Russell
Aug 28, 2003·European Journal of Clinical Pharmacology·Kathleen BennettJohn Feely
Mar 27, 2004·Journal of Public Health·Mark AshworthAzeem Majeed
Apr 22, 2004·Clinical Genetics·S G Suther, P Goodson
May 29, 2004·Trends in Microbiology·Arturo Casadevall, Liise-anne Pirofski
Oct 27, 2004·European Journal of Clinical Pharmacology·Torben DybdahlIvar Sønbø Kristiansen
Mar 15, 2005·BMC Health Services Research·Atle Fretheim, Andrew D Oxman
Mar 24, 2005·European Journal of Clinical Pharmacology·K BehanSusan E Tett
Apr 7, 2005·Journal of Clinical Pharmacy and Therapeutics·A Helin-SalmivaaraT Klaukka
Sep 16, 2005·Applied Health Economics and Health Policy·Anne R MasonJonathan Cooke
Jul 28, 2006·The New England Journal of Medicine·Tim DoranMartin Roland
Dec 1, 2001·Nutrition Research Reviews·G S JacksonD Elmore
Feb 1, 2005·Expert Review of Pharmacoeconomics & Outcomes Research·Elias MossialosCaroline Rudisill

❮ Previous
Next ❯

Citations

Apr 20, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Jane Bourke, Stephen Roper
Sep 17, 2013·PharmacoEconomics·Phill O'NeillJon Sussex
Dec 24, 2008·Family Practice·Pia Bastholm RahmnerInger Holmström
Aug 27, 2011·BMC Health Services Research·Ingmarie SkoglundMargareta Möller
Mar 10, 2012·BMC Health Services Research·Francisco Javier GarjónJose Ramón Loayssa
Mar 20, 2013·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Christine FukadaMurray Krahn
May 30, 2013·Primary Health Care Research & Development·Rachel HoutenClaire McLeod
Oct 22, 2014·BMC Health Services Research·Ágnes Lublóy
Jul 28, 2012·Research in Social & Administrative Pharmacy : RSAP·Vibhu PaudyalDerek Stewart
Sep 4, 2010·Research in Social & Administrative Pharmacy : RSAP·Kent E M GrovesNeil J MacKinnon
Jan 17, 2009·Health Policy·Zoë Slote Morris, Peter John Clarkson
Jul 26, 2011·Journal of Obesity·Tomas ForslundBjörn Wettermark
Dec 17, 2014·Journal of Evaluation in Clinical Practice·Luis Flores
Jul 11, 2008·Journal of Clinical Pharmacy and Therapeutics·D Chauhan, A Mason
Jul 28, 2012·Journal of Evaluation in Clinical Practice·Cindy HuangJaekyu Shin
Feb 3, 2011·British Journal of Clinical Pharmacology·Wan A H Wan Md AdnanCatherine A Wall
Apr 5, 2014·Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy·Damon BurnLindsay Edwards
Jul 23, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D NathwaniC Eckmann
Sep 13, 2013·The Journal of Antimicrobial Chemotherapy·Diane Ashiru-OredopeUNKNOWN English Surveillance Programme for Antimicrobial Utilization and Resistance Oversight Group
Nov 9, 2014·American Journal of Alzheimer's Disease and Other Dementias·Yun-Ping ChangYuan-Han Yang
Feb 13, 2018·European Journal of Clinical Pharmacology·Irene ErikssonMia von Euler
May 15, 2018·Australian Health Review : a Publication of the Australian Hospital Association·Jacqueline TudballNick Zwar
Dec 16, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Brian GodmanLars L Gustafsson
Jan 10, 2013·MMW Fortschritte der Medizin·Thomas Kühlein, Tobias Freund
Oct 6, 2009·Applied Health Economics and Health Policy·Björn WettermarkFlora M Haaijer-Ruskamp
Dec 30, 2009·Applied Health Economics and Health Policy·Catherine SermetJean-Pierre Reynier
Nov 7, 2021·BMC Health Services Research·Kristina MedlinskieneDuncan Petty
Nov 19, 2021·Journal of the Royal Society of Medicine·Matias Ortiz De ZarateCarmine Ornaghi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.